Alkem Laboratories gets EIR for St Louis facility

13 May 2020 Evaluate

Alkem Laboratories has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA), for its St Louis facility, USA. The inspection has been closed by the USFDA.

Earlier, the inspection was conducted by the USFDA from January 27, 2020 to February 6, 2020. At the end of the inspection, the company had received Form 483 with three observations.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

Alkem Laboratories Share Price

5765.40 107.60 (1.90%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×